References
- Huang M. E., Ye Y. C., Chen S. R., Chai J. R., Lu J. X., Zhao L., Gu L. J., Wang Z. Y. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–572
- Caistagne S., Chomienne C., Daniel M. T., Ballerini P., Berger R., Fenaux P., Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. 1. Clinical results. Blood 1990; 76: 1704–1709
- Fenaux P., Robert M. C., Castaigne S., Archimbaud E., Chomienne C., Link H., Guerci A., Bowen D., Sanz M., Fey M., Fegueux N., Chastang C., Degos L. A multicenter trial comparing all trans retinoic acid plus chemotherapy (ATRA + CT) and CT alone in newly diagnosed acute promyelocytic leukemia (APL). Proc. 29th Annual Meeting of the American Society of Clinical Oncology. 1993; 12–300
- Chomienne C., Ballerini P., Balitrand N., Daniel M. T., Fenaux P., Castaigne S., Degos L. All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: Structure-function relationship. Blood 1990; 76: 1710–1717
- Alles A. J., Sulik K. K. Retinoic acid-induced limb-reduction defects: Perturbation of zones of programmed cell death as a pathogenetic mechanism. Teratology 1989; 40: 163–171
- Martin S. J., Bradley J. G., Cotter T. G. HL60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin. Exp. Immunol. 1990; 79: 448–452
- Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Gallon D. A. G., Gralnick H. R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemias. Ann. Intern. Med. 1985; 103: 626–633
- Nicoletti I., Migliorati G., Pagliacci M. C., Grignani F., Riccardi C. A rapid and simple method for measuring of thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Meth. 1991; 139: 271–279
- Kerr J. F. R., Wyllie A. H., Currie A. R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972; 26: 239–257
- Williams G. T., Smith C. A., Spooncer E., Dexter T. M., Taylor D. R. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 1990; 343: 76–80
- Chomienne C., Barbey S., Balitrand N., Degos L., Sachs L. Regulation of Bcl-2 and cell death by all-trans retinoic acid in acute promyelocytic leukemia. Proc. 83rd Annual Meeting of the American Association for Cancer Research. 1992; 33: 41
- Korsmeyer S. J. Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 1992; 80: 879–886
- Degos L., Shroot B., De The H., Chomienne C., Wang Z. Y., Castaigne S. Retinoic acid in hematopoietic differentiation. Nouv. Rev. Francaise D'Hematol. 1990; 32: 25–38
- Ojeda F., Guarda M. I., Maldonado G., Folch H. Protein kinase C involvement in thymocyte apoptosis induced by hydrocortisone. Cell. Immunol. 1990; 125: 535–539
- Suedhoff T., Birckbichler P. J., Lee K. N., Conway E., Patterson M. K. Differential expression of transglutaminase in human erythroleukemia cells in response to retinoic acid. Cancer Res. 1990; 50: 7830–7834
- Chen Z. X., Xue Y. Q., Zhang R., Tao R. F., Xia X. M., Li C., Wang W., Zu W. Y., Yao X. Z., Ling B. J. A clinical and experimental study on all-trans retinoic acid treated acute promyelocytic leukemia patients. Blood 1991; 78: 1413–1419
- Miller W. H., Kakizuka A., Frankel S. R. Re-verse-transcriptase polymerase-chain reaction for the rearranged retinoic acid receptor-a predicts response to retinoic acid therapy and detects minimal residual disease in acute promyelocytic leukemia. Proc. 28th Annual Meeting of the American Society of Clinical Oncology. 1992; 11: 259
- Savill J. S., Wyllie A. H., Henson J. E., Walport M. J., Henson P. M., Haslett C. Macrophage phagocytosis of ageing neutrophils in inflammation: Programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest. 1989; 83: 865–875